| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |